Regeneron Pharmaceuticals Inc. (REGN)


Analysis of Debt

Difficulty: Advanced


Total Debt (Carrying Amount)

Regeneron Pharmaceuticals Inc., Statement of Financial Position, Debt

USD $ in thousands

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Capital and facility lease obligations, current portion –  –  129,557  1,789  1,353 
Convertible senior notes, current portion –  –  –  10,802  – 
Capital and facility lease obligations, excluding current portion 708,500  703,453  351,569  362,919  310,938 
Convertible senior notes, excluding current portion –  –  –  –  146,773 
Total debt (carrying amount) 708,500  703,453  481,126  375,510  459,064 

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

Item Description The company
Total debt (carrying amount) Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. Regeneron Pharmaceuticals Inc.’s total debt increased from 2016 to 2017 and from 2017 to 2018.

Total Debt (Fair Value)

Microsoft Excel LibreOffice Calc
Dec 31, 2018
Selected Financial Data (USD $ in thousands)
Capital and facility lease obligations 708,500 
Convertible senior notes – 
Total debt (fair value) 708,500 
Ratio
Debt, fair value to carrying amount 1.00

Based on: 10-K (filing date: 2019-02-07).


Weighted-average Interest Rate on Debt

Weighted-average interest rate on debt: 9.04%

Interest Rate Debt Amount1 Interest Rate × Debt Amount Weighted-average Interest Rate2
9.04% 708,500  64,048 
Total 708,500  64,048  9.04%

Based on: 10-K (filing date: 2019-02-07).

1 USD $ in thousands

2 Weighted-average interest rate = 100 × 64,048 ÷ 708,500 = 9.04%